Senzar Asset Management as of Dec. 31, 2017
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 30 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sanofi-Aventis SA (SNY) | 11.0 | $43M | 1000k | 42.99 | |
| Regeneron Pharmaceuticals (REGN) | 10.9 | $43M | 114k | 375.96 | |
| Mylan Nv | 6.5 | $26M | 607k | 42.33 | |
| Aetna | 6.5 | $25M | 140k | 180.39 | |
| CVS Caremark Corporation (CVS) | 5.8 | $23M | 316k | 72.52 | |
| Ironwood Pharmaceuticals (IRWD) | 5.5 | $22M | 1.4M | 14.99 | |
| Abbott Laboratories (ABT) | 4.5 | $18M | 307k | 57.07 | |
| Novartis (NVS) | 4.4 | $17M | 205k | 83.92 | |
| Aerie Pharmaceuticals | 4.2 | $17M | 278k | 59.80 | |
| Allergan Plc pfd conv ser a | 3.7 | $15M | 25k | 586.67 | |
| Endologix | 3.0 | $12M | 2.2M | 5.35 | |
| Cerner Corporation | 2.9 | $11M | 169k | 67.38 | |
| Tg Therapeutics (TGTX) | 2.8 | $11M | 1.4M | 8.20 | |
| Medtronic (MDT) | 2.8 | $11M | 138k | 80.80 | |
| Halozyme Therapeutics (HALO) | 2.8 | $11M | 538k | 20.26 | |
| MiMedx (MDXG) | 2.3 | $9.2M | 726k | 12.62 | |
| Alder Biopharmaceuticals | 2.3 | $9.0M | 787k | 11.45 | |
| Select Medical Holdings Corporation (SEM) | 2.2 | $8.6M | 491k | 17.63 | |
| Revance Therapeutics (RVNC) | 2.2 | $8.5M | 236k | 35.76 | |
| Allergan | 2.0 | $8.0M | 49k | 163.33 | |
| Concert Pharmaceuticals I equity | 1.8 | $7.1M | 276k | 25.87 | |
| Sientra | 1.7 | $6.8M | 485k | 14.06 | |
| Avexis | 1.6 | $6.4M | 58k | 110.48 | |
| Healthsouth | 1.5 | $5.8M | 116k | 49.52 | |
| NxStage Medical | 1.3 | $5.2M | 213k | 24.29 | |
| Theravance Biopharma (TBPH) | 1.2 | $4.8M | 172k | 27.89 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $3.7M | 180k | 20.77 | |
| Foamix Pharmaceuticals | 0.6 | $2.3M | 377k | 6.02 | |
| Inotek Pharmaceuticals | 0.4 | $1.7M | 637k | 2.61 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $1.2M | 5.5k | 210.00 |
